Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
Sam Altman, the CEO of OpenAI, now says he is more confident of a fast AI takeoff. A fast AI takeoff is more possible than he ...
"And of course it's smarter than us. Of course, it can do things we can't, but also who really cares? I think it's only weird ...